Literature DB >> 18533549

Post-surgical role of botulinum toxin-A injection in patients with head and neck cancer: personal experience.

M R Marchese1, G Almadori, A Giorgio, G Paludetti.   

Abstract

Personal experience is discussed in the use of botulinum neurotoxin injections into both parotids, performed in order to transiently reduce salivation in patients undergoing major ablative and ablative-reconstructive oncologic surgery for head and neck tumours. Overall, 8 adult patients (2 female, 6 male) have been treated. Six cases were affected by pharyngocutaneous fistulas, one by severe sialorrhoea and one recurrent sialocele. After the injection, patients were regularly observed at follow-up and asked to give their subjective assessment of salivary flow. Investigations concerning possible complaints, including side-effects, as well as complete examination of the head and neck area were performed. Follow-up periods ranged from 12 to 24 weeks (mean 20 weeks). Following botulinum neurotoxin injection, the fistula was dry after a mean period of 4.5 days (min 3 days, max 8 days) and was closed 6.6 days (min 5 days, max 8 days) later. The patient affected by severe hypersalivation reported subjective improvement in sialorrhoea 4 days post-treatment. The patient affected by recurrent sialocele, required only one aspiration of fluid two days after the treatment, after which there were no further problems. Post-operative saliva-related complications significantly increase patient morbidity and hospital stay after major tumour surgery. The easy, safe and effective treatment with botulinum neurotoxin injection, observed in our experience, suggest its significant role as a useful option in the post-operative saliva-related complications.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18533549      PMCID: PMC2640068     

Source DB:  PubMed          Journal:  Acta Otorhinolaryngol Ital        ISSN: 0392-100X            Impact factor:   2.124


  17 in total

1.  Botulinum toxin to reduce saliva flow: selected indications for ultrasound-guided toxin application into salivary glands.

Authors:  Maik Ellies; Rainer Laskawi; Saskia Rohrbach-Volland; Christian Arglebe; Wolfgang Beuche
Journal:  Laryngoscope       Date:  2002-01       Impact factor: 3.325

2.  The surgical treatment of drooling. A ten-year review.

Authors:  T F Wilkie; G S Brody
Journal:  Plast Reconstr Surg       Date:  1977-06       Impact factor: 4.730

3.  Post-traumatic parotid fistulae and sialoceles. A prospective study of conservative management in 51 cases.

Authors:  D Parekh; G Glezerson; M Stewart; J Esser; H H Lawson
Journal:  Ann Surg       Date:  1989-01       Impact factor: 12.969

4.  Localised autonomic failure due to botulinum toxin injection.

Authors:  A C Mann
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-11       Impact factor: 10.154

5.  Sialorrhea in amyotrophic lateral sclerosis: a hypothesis of a new treatment--botulinum toxin A injections of the parotid glands.

Authors:  K O Bushara
Journal:  Med Hypotheses       Date:  1997-04       Impact factor: 1.538

Review 6.  Botulinum toxin: basic science and clinical uses in otolaryngology.

Authors:  A Blitzer; L Sulica
Journal:  Laryngoscope       Date:  2001-02       Impact factor: 3.325

7.  Injections of botulinum toxin A into the salivary glands improve sialorrhoea in amyotrophic lateral sclerosis.

Authors:  R Giess; M Naumann; E Werner; R Riemann; M Beck; I Puls; C Reiners; K V Toyka
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-07       Impact factor: 10.154

8.  Treatment of dysfunction of the cricopharyngeal muscle with botulinum A toxin: introduction of a new, noninvasive method.

Authors:  I Schneider; W F Thumfart; C Pototschnig; H E Eckel
Journal:  Ann Otol Rhinol Laryngol       Date:  1994-01       Impact factor: 1.547

9.  Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): a 12-year experience in more than 900 patients.

Authors:  A Blitzer; M F Brin; C F Stewart
Journal:  Laryngoscope       Date:  1998-10       Impact factor: 3.325

10.  Conservative management of post-traumatic parotid fistulae and sialoceles: a prospective study.

Authors:  R Landau; M Stewart
Journal:  Br J Surg       Date:  1985-01       Impact factor: 6.939

View more
  4 in total

1.  Use of injectable spasticity management agents in a cancer center.

Authors:  Jack Fu; Carolina Gutiérrez; Eduardo Bruera; Ying Guo; Shana Palla
Journal:  Support Care Cancer       Date:  2012-11-11       Impact factor: 3.603

Review 2.  Toxin yet not toxic: Botulinum toxin in dentistry.

Authors:  M S Archana
Journal:  Saudi Dent J       Date:  2015-12-21

Review 3.  Non-Surgical Strategies for Assisting Closure of Pharyngocutaneous Fistula after Total Laryngectomy: A Systematic Review of the Literature.

Authors:  Luca Giovanni Locatello; Giuseppe Licci; Giandomenico Maggiore; Oreste Gallo
Journal:  J Clin Med       Date:  2021-12-24       Impact factor: 4.241

Review 4.  Botulinum Neurotoxins and Cancer-A Review of the Literature.

Authors:  Shivam Om Mittal; Bahman Jabbari
Journal:  Toxins (Basel)       Date:  2020-01-05       Impact factor: 4.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.